CVS
41
-4
BSX
64
-3
AMZN
61
-5
HBI
58
3
LEN
50
-2
EBAY
42
-2
SJM
9
-5
TSCO
44
-4
CHD
54
4
PDCO
29
2
PBI
56
-2
BA
47
2
AN
50
-5
NAVI
52
-2
DHR
32
-6
GILD
47
-8
ISRG
71
-5
DTE
43
5
TJX
62
-2
ORLY
60
-5
CVS
41
-4
BSX
64
-3
AMZN
61
-5
HBI
58
3
LEN
50
-2
EBAY
42
-2
SJM
9
-5
TSCO
44
-4
CHD
54
4
PDCO
29
2
PBI
56
-2
BA
47
2
AN
50
-5
NAVI
52
-2
DHR
32
-6
GILD
47
-8
ISRG
71
-5
DTE
43
5
TJX
62
-2
ORLY
60
-5
Financhill
Back

UPAR Ultra Risk Parity ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Buy
72

UPAR
UPAR Ultra Risk Parity ETF

Last Price:
13.50
Seasonality Move:
6.99%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
42.56
Seasonality Move:
17.03%
Buy
72
UPAR Ultra Risk Parity ETF (UPAR) is a Buy

Is UPAR Ultra Risk Parity ETF a Buy, Sell or Hold?

  • The current UPAR Ultra Risk Parity ETF [UPAR] share price is $13.45. The Score for UPAR is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
  • UPAR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

UPAR Stock Price Chart

What is UPAR Ultra Risk Parity ETF's stock price today?

  • The UPAR Ultra Risk Parity ETF share price today is $13.45
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UPAR is experiencing slight selling pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

UPAR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.21 Sell
Relative Strength Index (14 RSI): 32.95 Sell
Chaikin Money Flow: -1565 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.77 - 14.33) Sell
Bollinger Bands (100): (13.75 - 14.55) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

UPAR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.79 Sell
20-day SMA: 13.96 Sell
50-day SMA: 14.35 Sell
200-day SMA: 13.81 Sell
8-day EMA: 13.72 Sell
20-day EMA: 13.94 Sell
50-day EMA: 14.14 Sell
200-day EMA: 13.9 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

UPAR Ultra Risk Parity ETF Earnings Growth & UPAR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

UPAR Ultra Risk Parity ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):